Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02510950
What this trial is testing

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IV
Washington University School of Medicine 1
Testing effectiveness (Phase 2)Looking for participantsNCT06059690
What this trial is testing

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Who this might be right for
Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
Jonsson Comprehensive Cancer Center 50
Early research (Phase 1)Study completedNCT00401024
What this trial is testing

Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Early research (Phase 1)Study completedNCT02820584
What this trial is testing

A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma

Who this might be right for
de Novo Glioblastoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 20
Early research (Phase 1)Looking for participantsNCT06917885
What this trial is testing

CUE-102 in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastomaGlioma, Malignant
David Reardon, MD 18
Testing effectiveness (Phase 2)Ended earlyNCT02227576
What this trial is testing

Prevention of Thrombocytopenia in Glioblastoma Patients

Who this might be right for
ThrombocytopeniaGlioblastoma
University Hospital, Lille 20
Testing effectiveness (Phase 2)Looking for participantsNCT07511725
What this trial is testing

Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma

Who this might be right for
Glioblastoma (GBM)
Second Affiliated Hospital, Zhejiang University, School of Medicine 38
Large-scale testing (Phase 3)Active Not RecruitingNCT05118776
What this trial is testing

Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM

Who this might be right for
Recurrent Glioblastoma
Ascletis Pharmaceuticals Co., Ltd. 136
Early research (Phase 1)Study completedNCT00968240
What this trial is testing

Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 30
Testing effectiveness (Phase 2)Looking for participantsNCT06102525
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Who this might be right for
Glioblastoma
Rznomics, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT00028678
What this trial is testing

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 45
Testing effectiveness (Phase 2)Study completedNCT03466450
What this trial is testing

Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 75
Testing effectiveness (Phase 2)Study completedNCT00005859
What this trial is testing

Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 136
Testing effectiveness (Phase 2)Study completedNCT03746080
What this trial is testing

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma With Primitive Neuronal ComponentGliosarcoma+2 more
Lawrence D Recht 21
Large-scale testing (Phase 3)UnknownNCT00045968
What this trial is testing

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Who this might be right for
Glioblastoma MultiformeGlioblastomaGBM+4 more
Northwest Biotherapeutics 348
Not applicableUnknownNCT02613988
What this trial is testing

Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas

Who this might be right for
Adult Glioblastoma
Asan Medical Center 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04762069
What this trial is testing

Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme, Adult
CNS Pharmaceuticals, Inc. 252
Early research (Phase 1)Ended earlyNCT00272870
What this trial is testing

Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy

Who this might be right for
Glioblastoma Multiforme (WHO Grade IV)Anaplastic Astrocytoma (WHO Grade III)
Children's Hospital Medical Center, Cincinnati 1
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Testing effectiveness (Phase 2)UnknownNCT04450160
What this trial is testing

Trial of AEO in New Glioblastoma (GBM)

Who this might be right for
Glioblastoma Multiforme
MetVital, Inc. 80
Next Page